Citadel Advisors’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $940K | Sell |
94,256
-1,085,466
| -92% | -$10.8M | ﹤0.01% | 3378 |
|
|
2025
Q1 | $7.04M | Sell |
1,179,722
-252,540
| -18% | -$1.51M | ﹤0.01% | 1499 |
|
|
2024
Q4 | $11M | Buy |
1,432,262
+196,003
| +16% | +$1.51M | ﹤0.01% | 1265 |
|
|
2024
Q3 | $12.6M | Buy |
1,236,259
+538,927
| +77% | +$5.5M | ﹤0.01% | 1107 |
|
|
2024
Q2 | $10.3M | Sell |
697,332
-471,332
| -40% | -$6.99M | ﹤0.01% | 1201 |
|
|
2024
Q1 | $15.9M | Buy |
1,168,664
+38,876
| +3% | +$530K | ﹤0.01% | 1010 |
|
|
2023
Q4 | $12.4M | Buy |
1,129,788
+122,216
| +12% | +$1.34M | ﹤0.01% | 1102 |
|
|
2023
Q3 | $11M | Sell |
1,007,572
-187,697
| -16% | -$2.06M | ﹤0.01% | 1111 |
|
|
2023
Q2 | $15.8M | Sell |
1,195,269
-248,231
| -17% | -$3.29M | ﹤0.01% | 926 |
|
|
2023
Q1 | $19.6M | Buy |
1,443,500
+88,073
| +6% | +$1.2M | ﹤0.01% | 857 |
|
|
2022
Q4 | $26.5M | Buy |
1,355,427
+33,544
| +3% | +$655K | 0.01% | 729 |
|
|
2022
Q3 | $25.2M | Buy |
1,321,883
+608,171
| +85% | +$11.6M | 0.01% | 697 |
|
|
2022
Q2 | $14.7M | Buy |
713,712
+192,241
| +37% | +$3.96M | ﹤0.01% | 1027 |
|
|
2022
Q1 | $16.8M | Sell |
521,471
-477,470
| -48% | -$15.4M | ﹤0.01% | 1036 |
|
|
2021
Q4 | $46.5M | Buy |
998,941
+23,523
| +2% | +$1.1M | 0.01% | 510 |
|
|
2021
Q3 | $26.3M | Sell |
975,418
-18,978
| -2% | -$512K | 0.01% | 742 |
|
|
2021
Q2 | $25.5M | Buy |
994,396
+483,398
| +95% | +$12.4M | 0.01% | 814 |
|
|
2021
Q1 | $17.5M | Sell |
510,998
-286,316
| -36% | -$9.79M | ﹤0.01% | 1019 |
|
|
2020
Q4 | $27M | Sell |
797,314
-100,975
| -11% | -$3.41M | 0.01% | 705 |
|
|
2020
Q3 | $22.2M | Buy |
+898,289
| New | +$22.2M | 0.01% | 711 |
|